Send mail to Author

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    _    _               _____   __    __     ___    
 |__  //  | || | ||   ____     |  ___|| \ \\ / //   / _ \\  
   / //   | || | ||  |    \\   | ||__    \ \/ //   | / \ || 
  / //__  | \\_/ ||  | [] ||   | ||__     \  //    | \_/ || 
 /_____||  \____//   |  __//   |_____||    \//      \___//  
 `-----`    `---`    |_|`-`    `-----`      `       `---`   
                     `-`
 


Back to frontdoor view

OPUS4 Logo